{"id":"W4387952420","doi":"10.1055/s-0043-1771661","title":"Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response during ustekinumab maintenance therapy: week 16 results from the phase 3b POWER trial","year":2023,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Maintenance therapy; Internal medicine; Randomized controlled trial; Disease; Chemotherapy; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002693061,0.0007771482,0.001807693,0.0002559684,0.0002137389,0.001068952,0.000601983,0.001005683,0.003164697],"category_scores_gemma":[0.002447502,0.0002737473,0.002182491,0.0002876746,0.0008854872,0.0008588998,0.0003770985,0.002268698,0.0007362019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004823886,"about_ca_system_score_gemma":0.0005696255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002574422,"about_ca_topic_score_gemma":0.000454896,"domain_scores_codex":[0.999063,0.0005374267,0.00005998674,0.0001029007,0.00008309247,0.000153622],"domain_scores_gemma":[0.9981583,0.0006973675,0.0004970041,0.0001938094,0.00009224061,0.0003613657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8629211,0.007921814,0.008301594,0.0008531935,0.002664745,0.0001422523,0.0001388772,0.001262907,0.008901263,0.0001730677,0.002222989,0.1044963],"study_design_scores_gemma":[0.7195462,0.2345436,0.0369714,0.0001291507,0.001923883,0.0003908821,0.00005306298,0.000935633,0.002623577,0.0004985997,0.002346684,0.00003741335],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897083,0.006489386,0.0003421255,0.0005595019,0.0001037381,0.0004641928,0.0005195871,0.00006579134,0.001747403],"genre_scores_gemma":[0.9953348,0.001465937,0.0003915588,0.0004611053,0.0001311022,0.0004653391,0.0007572143,0.00001679252,0.0009761021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003164697,"threshold_uncertainty_score":0.01424241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01265814090697608,"score_gpt":0.2539851544492528,"score_spread":0.2413270135422767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}